Skip to main content
Top
Published in: Immunity & Ageing 1/2024

Open Access 01-12-2024 | COVID-19 | Research

Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients

Authors: Mailton Prestes Madruga, Lucas Kich Grun, Letícya Simone Melo Dos Santos, Frederico Orlando Friedrich, Douglas Bitencourt Antunes, Marcella Elesbão Fogaça Rocha, Pedro Luis Silva, Gilson P. Dorneles, Paula Coelho Teixeira, Tiago Franco Oliveira, Pedro R.T. Romão, Lucas Santos, José Claudio Fonseca Moreira, Vinicius Schenk Michaelsen, Marcelo Cypel, Marcos Otávio Brum Antunes, Marcus Herbert Jones, Florencia María Barbé-Tuana, Moisés Evandro Bauer

Published in: Immunity & Ageing | Issue 1/2024

Login to get access

Abstract

Background

Several risk factors have been involved in the poor clinical progression of coronavirus disease-19 (COVID-19), including ageing, and obesity. SARS-CoV-2 may compromise lung function through cell damage and paracrine inflammation; and obesity has been associated with premature immunosenescence, microbial translocation, and dysfunctional innate immune responses leading to poor immune response against a range of viruses and bacterial infections. Here, we have comprehensively characterized the immunosenescence, microbial translocation, and immune dysregulation established in hospitalized COVID-19 patients with different degrees of body weight.

Results

Hospitalised COVID-19 patients with overweight and obesity had similarly higher plasma LPS and sCD14 levels than controls (all p < 0.01). Patients with obesity had higher leptin levels than controls. Obesity and overweight patients had similarly higher expansions of classical monocytes and immature natural killer (NK) cells (CD56+CD16) than controls. In contrast, reduced proportions of intermediate monocytes, mature NK cells (CD56+CD16+), and NKT were found in both groups of patients than controls. As expected, COVID-19 patients had a robust expansion of plasmablasts, contrasting to lower proportions of major T-cell subsets (CD4 + and CD8+) than controls. Concerning T-cell activation, overweight and obese patients had lower proportions of CD4+CD38+ cells than controls. Contrasting changes were reported in CD25+CD127low/neg regulatory T cells, with increased and decreased proportions found in CD4+ and CD8+ T cells, respectively. There were similar proportions of T cells expressing checkpoint inhibitors across all groups. We also investigated distinct stages of T-cell differentiation (early, intermediate, and late-differentiated – TEMRA). The intermediate-differentiated CD4 + T cells and TEMRA cells (CD4+ and CD8+) were expanded in patients compared to controls. Senescent T cells can also express NK receptors (NKG2A/D), and patients had a robust expansion of CD8+CD57+NKG2A+ cells than controls. Unbiased immune profiling further confirmed the expansions of senescent T cells in COVID-19.

Conclusions

These findings suggest that dysregulated immune cells, microbial translocation, and T-cell senescence may partially explain the increased vulnerability to COVID-19 in subjects with excess of body weight.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–9.PubMedPubMedCentralCrossRef Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–9.PubMedPubMedCentralCrossRef
2.
go back to reference Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O’Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9:350–9.PubMedPubMedCentralCrossRef Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O’Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9:350–9.PubMedPubMedCentralCrossRef
3.
go back to reference Ho FK, Petermann-Rocha F, Gray SR, Jani BD, Katikireddi SV, Niedzwiedz CL, et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE. 2020;15:e0241824.PubMedPubMedCentralCrossRef Ho FK, Petermann-Rocha F, Gray SR, Jani BD, Katikireddi SV, Niedzwiedz CL, et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE. 2020;15:e0241824.PubMedPubMedCentralCrossRef
4.
go back to reference Hunsche C, Hernandez O, De La Fuente M. Impaired immune response in old mice suffering from obesity and premature immunosenescence in adulthood. Journals Gerontol - Ser Biol Sci Med Sci. 2016;71:983–91.CrossRef Hunsche C, Hernandez O, De La Fuente M. Impaired immune response in old mice suffering from obesity and premature immunosenescence in adulthood. Journals Gerontol - Ser Biol Sci Med Sci. 2016;71:983–91.CrossRef
5.
go back to reference Yan T, Xiao R, Wang N, Shang R, Lin G. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities. Theranostics. 2021;11:8234–53.PubMedPubMedCentralCrossRef Yan T, Xiao R, Wang N, Shang R, Lin G. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities. Theranostics. 2021;11:8234–53.PubMedPubMedCentralCrossRef
7.
go back to reference Barbé-Tuana F, Funchal G, Schmitz CRR, Maurmann RM, Bauer ME. The interplay between immunosenescence and age-related diseases. Semin Immunopathol. 2020;42:545–57.PubMedPubMedCentralCrossRef Barbé-Tuana F, Funchal G, Schmitz CRR, Maurmann RM, Bauer ME. The interplay between immunosenescence and age-related diseases. Semin Immunopathol. 2020;42:545–57.PubMedPubMedCentralCrossRef
8.
go back to reference Spielmann G, Johnston CA, O’Connor DP, Foreyt JP, Simpson RJ. Excess body mass is associated with T cell differentiation indicative of immune ageing in children. Clin Exp Immunol. 2014;176:246–54.PubMedPubMedCentralCrossRef Spielmann G, Johnston CA, O’Connor DP, Foreyt JP, Simpson RJ. Excess body mass is associated with T cell differentiation indicative of immune ageing in children. Clin Exp Immunol. 2014;176:246–54.PubMedPubMedCentralCrossRef
9.
go back to reference Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science (New York, NY). 2022;375:1122–7. Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science (New York, NY). 2022;375:1122–7.
10.
go back to reference Evangelou K, Veroutis D, Paschalaki K, Foukas PG, Lagopati N, Dimitriou M, et al. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis. Eur Respir J. 2022;60:2102951.PubMedPubMedCentralCrossRef Evangelou K, Veroutis D, Paschalaki K, Foukas PG, Lagopati N, Dimitriou M, et al. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis. Eur Respir J. 2022;60:2102951.PubMedPubMedCentralCrossRef
11.
go back to reference Tsuji S, Minami S, Hashimoto R, Konishi Y, Suzuki T, Kondo T, et al. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response. Nat Aging. 2022;2:115–24.PubMedPubMedCentralCrossRef Tsuji S, Minami S, Hashimoto R, Konishi Y, Suzuki T, Kondo T, et al. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response. Nat Aging. 2022;2:115–24.PubMedPubMedCentralCrossRef
12.
go back to reference Hoel H, Heggelund L, Reikvam DH, Stiksrud B, Ueland T, Michelsen AE et al. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. J Intern Med. 2021;289. Hoel H, Heggelund L, Reikvam DH, Stiksrud B, Ueland T, Michelsen AE et al. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. J Intern Med. 2021;289.
13.
go back to reference Teixeira PC, Dorneles GP, Santana Filho PC, Da Silva IM, Schipper LL, Postiga IAL, et al. Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients. Int Immunopharmacol. 2021;100:108125.PubMedPubMedCentralCrossRef Teixeira PC, Dorneles GP, Santana Filho PC, Da Silva IM, Schipper LL, Postiga IAL, et al. Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients. Int Immunopharmacol. 2021;100:108125.PubMedPubMedCentralCrossRef
14.
go back to reference Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533–5.PubMedPubMedCentralCrossRef Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533–5.PubMedPubMedCentralCrossRef
15.
go back to reference Gil-Manso S, Herrero-Quevedo D, Carbonell D, Martínez-Bonet M, Bernaldo-de-Quirós E, Kennedy-Batalla R, et al. Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission. PLoS Pathog. 2023;19:e1011432.PubMedPubMedCentralCrossRef Gil-Manso S, Herrero-Quevedo D, Carbonell D, Martínez-Bonet M, Bernaldo-de-Quirós E, Kennedy-Batalla R, et al. Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission. PLoS Pathog. 2023;19:e1011432.PubMedPubMedCentralCrossRef
16.
go back to reference Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369:eabc8511.PubMedPubMedCentralCrossRef Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369:eabc8511.PubMedPubMedCentralCrossRef
17.
go back to reference Gil-Manso S, Miguens Blanco I, López-Esteban R, Carbonell D, López-Fernández LA, West L, et al. Comprehensive flow cytometry profiling of the immune system in COVID-19 convalescent individuals. Front Immunol. 2021;12:793142.PubMedCrossRef Gil-Manso S, Miguens Blanco I, López-Esteban R, Carbonell D, López-Fernández LA, West L, et al. Comprehensive flow cytometry profiling of the immune system in COVID-19 convalescent individuals. Front Immunol. 2021;12:793142.PubMedCrossRef
19.
go back to reference Yang J, Chang T, Tang L, Deng H, Chen D, Luo J, et al. Increased expression of Tim-3 is associated with depletion of NKT cells in SARS-CoV-2 infection. Front Immunol. 2022;13:796682.PubMedPubMedCentralCrossRef Yang J, Chang T, Tang L, Deng H, Chen D, Luo J, et al. Increased expression of Tim-3 is associated with depletion of NKT cells in SARS-CoV-2 infection. Front Immunol. 2022;13:796682.PubMedPubMedCentralCrossRef
20.
go back to reference De Barros J-PP, Gautier T, Sali W, Adrie C, Choubley H, Charron E, et al. Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay. J Lipid Res. 2015;56:1363–9.CrossRef De Barros J-PP, Gautier T, Sali W, Adrie C, Choubley H, Charron E, et al. Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay. J Lipid Res. 2015;56:1363–9.CrossRef
21.
go back to reference Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74–80.PubMedCrossRef Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74–80.PubMedCrossRef
22.
go back to reference Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, et al. Human CD56bright NK cells: an update. J Immunol. 2016;196:2923–31.PubMedCrossRef Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, et al. Human CD56bright NK cells: an update. J Immunol. 2016;196:2923–31.PubMedCrossRef
23.
go back to reference Arana Echarri A, Struszczak L, Beresford M, Campbell JP, Jones RH, Thompson D, et al. Immune cell status, cardiorespiratory fitness and body composition among breast cancer survivors and healthy women: a cross sectional study. Front Physiol. 2023;14:1107070.PubMedPubMedCentralCrossRef Arana Echarri A, Struszczak L, Beresford M, Campbell JP, Jones RH, Thompson D, et al. Immune cell status, cardiorespiratory fitness and body composition among breast cancer survivors and healthy women: a cross sectional study. Front Physiol. 2023;14:1107070.PubMedPubMedCentralCrossRef
24.
go back to reference Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells. J Exp Med. 2006;203:1701–11.PubMedPubMedCentralCrossRef Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells. J Exp Med. 2006;203:1701–11.PubMedPubMedCentralCrossRef
25.
go back to reference Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GMA, Papagno L, et al. Memory CD8 + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379–85.PubMedCrossRef Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GMA, Papagno L, et al. Memory CD8 + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379–85.PubMedCrossRef
26.
go back to reference Soto-Heredero G, De Gómez MM, Escrig-Larena JI, Mittelbrunn M. Extremely differentiated T cell subsets contribute to tissue deterioration during aging. Annu Rev Immunol. 2023;41:181–205.PubMedCrossRef Soto-Heredero G, De Gómez MM, Escrig-Larena JI, Mittelbrunn M. Extremely differentiated T cell subsets contribute to tissue deterioration during aging. Annu Rev Immunol. 2023;41:181–205.PubMedCrossRef
27.
go back to reference Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Pea J, et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev. 2001;121:77–88.CrossRef Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Pea J, et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev. 2001;121:77–88.CrossRef
28.
go back to reference Laatifi M, Douzi S, Bouklouz A, Ezzine H, Jaafari J, Zaid Y, et al. Machine learning approaches in Covid-19 severity risk prediction in Morocco. J Big Data. 2022;9:5.PubMedPubMedCentralCrossRef Laatifi M, Douzi S, Bouklouz A, Ezzine H, Jaafari J, Zaid Y, et al. Machine learning approaches in Covid-19 severity risk prediction in Morocco. J Big Data. 2022;9:5.PubMedPubMedCentralCrossRef
31.
go back to reference Levine JH, Simonds EF, Bendall SC, Davis KL, Amir ED, Tadmor MD, et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell. 2015;162:184–97.PubMedPubMedCentralCrossRef Levine JH, Simonds EF, Bendall SC, Davis KL, Amir ED, Tadmor MD, et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell. 2015;162:184–97.PubMedPubMedCentralCrossRef
32.
go back to reference Yu L, Zhang X, Ye S, Lian H, Wang H, Ye J. Obesity and COVID-19: mechanistic insights from adipose tissue. J Clin Endocrinol Metab. 2022;107:1799–811.PubMedCrossRef Yu L, Zhang X, Ye S, Lian H, Wang H, Ye J. Obesity and COVID-19: mechanistic insights from adipose tissue. J Clin Endocrinol Metab. 2022;107:1799–811.PubMedCrossRef
33.
go back to reference Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944–955e8.PubMedCrossRef Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944–955e8.PubMedCrossRef
34.
go back to reference Dorneles GP, Teixeira PC, Peres A, Rodrigues Júnior LC, da Fonseca SG, Monteiro MC, et al. Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients. J Mol Med. 2023;101:183–95.PubMedCrossRef Dorneles GP, Teixeira PC, Peres A, Rodrigues Júnior LC, da Fonseca SG, Monteiro MC, et al. Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients. J Mol Med. 2023;101:183–95.PubMedCrossRef
35.
go back to reference Ahlawat S, Asha null, Sharma KK. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Res. 2020;286:198103.PubMedCrossRef Ahlawat S, Asha null, Sharma KK. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Res. 2020;286:198103.PubMedCrossRef
36.
go back to reference Su GL, Simmons RL, Wang SC. Lipopolysaccharide binding protein participation in cellular activation by LPS. Crit Rev Immunol. 1995;15:201–14.PubMedCrossRef Su GL, Simmons RL, Wang SC. Lipopolysaccharide binding protein participation in cellular activation by LPS. Crit Rev Immunol. 1995;15:201–14.PubMedCrossRef
37.
go back to reference Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–72.PubMedCrossRef Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–72.PubMedCrossRef
38.
go back to reference Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20:40–54.PubMedCrossRef Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20:40–54.PubMedCrossRef
39.
go back to reference Wang M, Zhang Y, Li C, Chang W, Zhang L. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment. Front Immunol. 2023;14:1180336.PubMedPubMedCentralCrossRef Wang M, Zhang Y, Li C, Chang W, Zhang L. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment. Front Immunol. 2023;14:1180336.PubMedPubMedCentralCrossRef
40.
go back to reference Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol. 2022;7:eabm5505.PubMedCrossRef Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol. 2022;7:eabm5505.PubMedCrossRef
41.
go back to reference Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Reviews Cardiol. 2018;15:505–22.CrossRef Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Reviews Cardiol. 2018;15:505–22.CrossRef
43.
go back to reference D’Abbondanza M, Martorelli EE, Ricci MA, De Vuono S, Migliola EN, Godino C, et al. Increased plasmatic NETs by-products in patients in severe obesity. Sci Rep. 2019;9:14678.ADSPubMedPubMedCentralCrossRef D’Abbondanza M, Martorelli EE, Ricci MA, De Vuono S, Migliola EN, Godino C, et al. Increased plasmatic NETs by-products in patients in severe obesity. Sci Rep. 2019;9:14678.ADSPubMedPubMedCentralCrossRef
44.
go back to reference Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5:eabd1554.PubMedPubMedCentralCrossRef Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5:eabd1554.PubMedPubMedCentralCrossRef
45.
go back to reference Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun. 2021;12:4117.ADSPubMedPubMedCentralCrossRef Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun. 2021;12:4117.ADSPubMedPubMedCentralCrossRef
46.
go back to reference Rajamanickam A, Kumar NP, Pandiarajan AN, Selvaraj N, Munisankar S, Renji RM, et al. Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals. Sci Rep. 2021;11:20254.ADSPubMedPubMedCentralCrossRef Rajamanickam A, Kumar NP, Pandiarajan AN, Selvaraj N, Munisankar S, Renji RM, et al. Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals. Sci Rep. 2021;11:20254.ADSPubMedPubMedCentralCrossRef
47.
go back to reference Jakobs K, Reinshagen L, Puccini M, Friebel J, Wilde A-CB, Alsheik A, et al. Disease severity in moderate-to-severe COVID-19 is associated with platelet hyperreactivity and innate immune activation. Front Immunol. 2022;13:844701.PubMedPubMedCentralCrossRef Jakobs K, Reinshagen L, Puccini M, Friebel J, Wilde A-CB, Alsheik A, et al. Disease severity in moderate-to-severe COVID-19 is associated with platelet hyperreactivity and innate immune activation. Front Immunol. 2022;13:844701.PubMedPubMedCentralCrossRef
48.
go back to reference Huntington ND, Vosshenrich CAJ, Di Santo JP. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol. 2007;7:703–14.PubMedCrossRef Huntington ND, Vosshenrich CAJ, Di Santo JP. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol. 2007;7:703–14.PubMedCrossRef
49.
go back to reference Jiang Y, Wei X, Guan J, Qin S, Wang Z, Lu H, et al. COVID-19 pneumonia: CD8 + T and NK cells are decreased in number but compensatory increased in cytotoxic potential. Clin Immunol. 2020;218:108516.PubMedPubMedCentralCrossRef Jiang Y, Wei X, Guan J, Qin S, Wang Z, Lu H, et al. COVID-19 pneumonia: CD8 + T and NK cells are decreased in number but compensatory increased in cytotoxic potential. Clin Immunol. 2020;218:108516.PubMedPubMedCentralCrossRef
50.
go back to reference Maucourant C, Filipovic I, Ponzetta A, Aleman S, Cornillet M, Hertwig L, et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci Immunol. 2020;5:eabd6832.PubMedPubMedCentralCrossRef Maucourant C, Filipovic I, Ponzetta A, Aleman S, Cornillet M, Hertwig L, et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci Immunol. 2020;5:eabd6832.PubMedPubMedCentralCrossRef
51.
go back to reference Krämer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-García R, et al. Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54:2650–2669e14.PubMedPubMedCentralCrossRef Krämer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-García R, et al. Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54:2650–2669e14.PubMedPubMedCentralCrossRef
52.
go back to reference O’Brien KL, Finlay DK. Immunometabolism and natural killer cell responses. Nat Rev Immunol. 2019;19:282–90.PubMedCrossRef O’Brien KL, Finlay DK. Immunometabolism and natural killer cell responses. Nat Rev Immunol. 2019;19:282–90.PubMedCrossRef
53.
go back to reference Hazeldine J, Hampson P, Lord JM. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell. 2012;11:751–9.PubMedCrossRef Hazeldine J, Hampson P, Lord JM. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell. 2012;11:751–9.PubMedCrossRef
54.
go back to reference Faria AMC, de Moraes SM, de Freitas LHF, Speziali E, Soares TF, Figueiredo-Neves SP, et al. Variation rhythms of lymphocyte subsets during healthy aging. Neuroimmunomodulation. 2008;15:365–79.PubMedCrossRef Faria AMC, de Moraes SM, de Freitas LHF, Speziali E, Soares TF, Figueiredo-Neves SP, et al. Variation rhythms of lymphocyte subsets during healthy aging. Neuroimmunomodulation. 2008;15:365–79.PubMedCrossRef
55.
go back to reference Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.PubMedPubMedCentralCrossRef Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.PubMedPubMedCentralCrossRef
56.
go back to reference Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021;27:451–7.PubMedCrossRef Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021;27:451–7.PubMedCrossRef
57.
go back to reference Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity. 2020;53:1296–1314e9.PubMedPubMedCentralCrossRef Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity. 2020;53:1296–1314e9.PubMedPubMedCentralCrossRef
58.
go back to reference Shoda H, Nagafuchi Y, Tsuchida Y, Sakurai K, Sumitomo S, Fujio K, et al. Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis. Arthritis Res Ther. 2017;19:111.PubMedPubMedCentralCrossRef Shoda H, Nagafuchi Y, Tsuchida Y, Sakurai K, Sumitomo S, Fujio K, et al. Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis. Arthritis Res Ther. 2017;19:111.PubMedPubMedCentralCrossRef
60.
go back to reference Zhao X, Gang X, He G, Li Z, Lv Y, Han Q, et al. Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020;11:595109.PubMedCrossRef Zhao X, Gang X, He G, Li Z, Lv Y, Han Q, et al. Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020;11:595109.PubMedCrossRef
61.
go back to reference De Candia P, Prattichizzo F, Garavelli S, Matarese GT, Cells. Warriors of SARS-CoV-2 infection. Trends Immunol. 2021;42:18–30.PubMedCrossRef De Candia P, Prattichizzo F, Garavelli S, Matarese GT, Cells. Warriors of SARS-CoV-2 infection. Trends Immunol. 2021;42:18–30.PubMedCrossRef
62.
go back to reference Seepathomnarong P, Ongarj J, Sophonmanee R, Seeyankem B, Chusri S, Surasombatpattana S, et al. Regulatory T cells decreased during recovery from mild COVID-19. Viruses. 2022;14:1688.PubMedPubMedCentralCrossRef Seepathomnarong P, Ongarj J, Sophonmanee R, Seeyankem B, Chusri S, Surasombatpattana S, et al. Regulatory T cells decreased during recovery from mild COVID-19. Viruses. 2022;14:1688.PubMedPubMedCentralCrossRef
63.
go back to reference Liu K, Yang T, Peng X-F, Lv S-M, Ye X-L, Zhao T-S, et al. A systematic meta-analysis of immune signatures in patients with COVID-19. Rev Med Virol. 2021;31:e2195.PubMedCrossRef Liu K, Yang T, Peng X-F, Lv S-M, Ye X-L, Zhao T-S, et al. A systematic meta-analysis of immune signatures in patients with COVID-19. Rev Med Virol. 2021;31:e2195.PubMedCrossRef
64.
go back to reference Barnova M, Bobcakova A, Urdova V, Kosturiak R, Kapustova L, Dobrota D, et al. Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19. Physiol Res. 2021;S227:47. Barnova M, Bobcakova A, Urdova V, Kosturiak R, Kapustova L, Dobrota D, et al. Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19. Physiol Res. 2021;S227:47.
65.
go back to reference Dorneles GP, Teixeira PC, Da Silva IM, Schipper LL, Santana Filho PC, Rodrigues Junior LC, et al. Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity. J Cell Physiol. 2022;237:3394–407.PubMedPubMedCentralCrossRef Dorneles GP, Teixeira PC, Da Silva IM, Schipper LL, Santana Filho PC, Rodrigues Junior LC, et al. Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity. J Cell Physiol. 2022;237:3394–407.PubMedPubMedCentralCrossRef
66.
go back to reference Coleman M, Zimmerly K, Yang X. Accumulation of CD28null senescent T-cells is associated with poorer outcomes in COVID19 patients. Biomolecules. 2021;11:1425.PubMedPubMedCentralCrossRef Coleman M, Zimmerly K, Yang X. Accumulation of CD28null senescent T-cells is associated with poorer outcomes in COVID19 patients. Biomolecules. 2021;11:1425.PubMedPubMedCentralCrossRef
67.
go back to reference Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130:4694–703.PubMedPubMedCentralCrossRef Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130:4694–703.PubMedPubMedCentralCrossRef
68.
go back to reference De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:3434.ADSPubMedPubMedCentralCrossRef De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:3434.ADSPubMedPubMedCentralCrossRef
69.
go back to reference Parisi MM, Grun LK, Lavandoski P, Alves LB, Bristot IJ, Mattiello R, et al. Immunosenescence induced by plasma from individuals with obesity caused cell signaling dysfunction and inflammation. Obesity. 2017;25:1523–31.PubMedCrossRef Parisi MM, Grun LK, Lavandoski P, Alves LB, Bristot IJ, Mattiello R, et al. Immunosenescence induced by plasma from individuals with obesity caused cell signaling dysfunction and inflammation. Obesity. 2017;25:1523–31.PubMedCrossRef
70.
go back to reference Grun LK, Teixeira N, da Mengden R, von, de Bastiani L, Parisi MA, Bortolin MM. TRF1 as a major contributor for telomeres’ shortening in the context of obesity. Free Radic Biol Med. 2018;129:286–95.PubMedCrossRef Grun LK, Teixeira N, da Mengden R, von, de Bastiani L, Parisi MA, Bortolin MM. TRF1 as a major contributor for telomeres’ shortening in the context of obesity. Free Radic Biol Med. 2018;129:286–95.PubMedCrossRef
71.
go back to reference Koch S, Larbi A, Özcelik D, Solana R, Gouttefangeas C, Attig S, et al. Cytomegalovirus infection. Ann Ny Acad Sci. 2007;1114:23–35.ADSCrossRef Koch S, Larbi A, Özcelik D, Solana R, Gouttefangeas C, Attig S, et al. Cytomegalovirus infection. Ann Ny Acad Sci. 2007;1114:23–35.ADSCrossRef
72.
go back to reference Álvarez-Heredia P, Reina-Alfonso I, Domínguez-Del-Castillo JJ, Gutiérrez-González C, Hassouneh F, Batista-Duharte A, et al. Accelerated T-cell immunosenescence in cytomegalovirus-seropositive individuals after severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2023;228:576–85.PubMedPubMedCentralCrossRef Álvarez-Heredia P, Reina-Alfonso I, Domínguez-Del-Castillo JJ, Gutiérrez-González C, Hassouneh F, Batista-Duharte A, et al. Accelerated T-cell immunosenescence in cytomegalovirus-seropositive individuals after severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2023;228:576–85.PubMedPubMedCentralCrossRef
74.
go back to reference Mahajan S, Kode V, Bhojak K, Karunakaran C, Lee K, Manoharan M, et al. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals. Sci Rep. 2021;11:13164.ADSPubMedPubMedCentralCrossRef Mahajan S, Kode V, Bhojak K, Karunakaran C, Lee K, Manoharan M, et al. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals. Sci Rep. 2021;11:13164.ADSPubMedPubMedCentralCrossRef
Metadata
Title
Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients
Authors
Mailton Prestes Madruga
Lucas Kich Grun
Letícya Simone Melo Dos Santos
Frederico Orlando Friedrich
Douglas Bitencourt Antunes
Marcella Elesbão Fogaça Rocha
Pedro Luis Silva
Gilson P. Dorneles
Paula Coelho Teixeira
Tiago Franco Oliveira
Pedro R.T. Romão
Lucas Santos
José Claudio Fonseca Moreira
Vinicius Schenk Michaelsen
Marcelo Cypel
Marcos Otávio Brum Antunes
Marcus Herbert Jones
Florencia María Barbé-Tuana
Moisés Evandro Bauer
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2024
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/s12979-024-00423-6

Other articles of this Issue 1/2024

Immunity & Ageing 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine